Extracellular Matrix Market Size & Growth | Report, 2021-2028
Se proyecta que el mercado de matrices extracelulares alcanzará los 52,72 millones de dólares en 2028 desde los 31,49 millones de dólares en 2021. Se estima que crecerá a una tasa compuesta anual del 7,6% de 2021 a 2028.
La matriz extracelular está presente en el lado exterior de los tejidos y ayuda a los tejidos a unir las células con colágeno. Se compone de proteínas estructurales, glicoproteínas, glucosaminoglucanos y proteoglicanos. La matriz extracelular permite que las células receptoras vuelvan a crecer y, por lo tanto, se utiliza en diversas aplicaciones, incluidos procedimientos de reparación cardíaca y vascular. Varios factores, como la creciente incidencia de enfermedades cardiovasculares y traumatismos y un aumento de los procedimientos de reconstrucción vascular, están impulsando el crecimiento del mercado de la matriz extracelular . Sin embargo, los desafíos durante el uso de la matriz extracelular descelularizada obstaculizan el crecimiento del mercado.
Personalice la investigación para adaptarla a sus necesidades
Podemos optimizar y adaptar el análisis y el alcance que no se cumplen a través de nuestras ofertas estándar. Esta flexibilidad le ayudará a obtener la información exacta que necesita para la planificación y la toma de decisiones de su negocio.
Mercado de matrices extracelulares: ideas estratégicas
CAGR (2021 - 2028)7,6%- Tamaño del mercado 2021
US$ 31,49 millones - Tamaño del mercado 2028
US$ 52,72 millones
Dinámica del mercado
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
Jugadores claves . Jugadores principales
- Anteris
- Aziyo Biologics, Inc.
- Grupo Coloplast
- Cook Biotecnología, Inc.
- DSM Biomédica
- baxter
- medtronic
- Merck KGaA
- Biológicos MTF
Panorama regional
- América del norte
- Europa
- Asia-Pacífico
- América del Sur y Central
- Medio Oriente y África
Segmentación de mercado
- Bovino
- Porcino
- Otra materia prima
- Reparación de tejidos blandos
- Reparación dural
- Cicatrización de la herida
- Reparación cardíaca
- Reparación pericárdica
- Reparación y reconstrucción vascular
- El PDF de muestra muestra la estructura del contenido y la naturaleza de la información con análisis cualitativo y cuantitativo.
Perspectivas del mercado
La creciente incidencia de trastornos cardiovasculares y traumatismos impulsa el crecimiento del mercado de la matriz extracelular
El aumento significativo de los casos de traumatismos ortopédicos y enfermedades cardiovasculares es el factor principal detrás del crecimiento del mercado mundial de matrices extracelulares. Como parte del tratamiento, la matriz extracelular ofrece varios beneficios en el tratamiento de diferentes lesiones crónicas causadas por cirugías, accidentes, enfermedades crónicas y otros incidentes. Además, la incidencia de insuficiencia cardíaca e infarto de miocardio está aumentando entre la población que envejece. El tratamiento mínimamente invasivo para estos procedimientos de tratamientos cardiovasculares requiere de una matriz extracelular. Un paciente que padece una enfermedad cardíaca no logra restaurar las propiedades funcionales del tejido cardíaco. La capacidad de la matriz extracelular para volver a crecer y promover la reparación y regeneración adaptativa permite a los pacientes recuperar sus funciones normales. Además, ha mostrado resultados clínicos prometedores para la ingeniería de tejidos en el tratamiento de enfermedades cardiovasculares y otras afecciones de salud.
Además, se espera que la creciente incidencia de enfermedades cardiovasculares impulse el crecimiento de la matriz extracelular. Por ejemplo, según datos de la OMS publicados en 2019, se estima que 17,9 millones de personas murieron a causa de enfermedades cardiovasculares en 2019, lo que representa el 32% de todas las muertes mundiales. De estas muertes, el 85% se debieron a ataques cardíacos y accidentes cerebrovasculares. Según el informe Europeo de Estadísticas de Enfermedades Cardiovasculares de 2017, en Europa, cada año las enfermedades cardiovasculares (ECV) causan 3,9 millones de muertes y más de 1,8 millones de muertes en la Unión Europea (UE).
Perspectivas basadas en materias primas
Según la materia prima, el mercado de la matriz extracelular se segmenta en materias primas bovinas, porcinas y otras. Se espera que el segmento porcino tenga la mayor participación en el mercado, mientras que se espera que el segmento bovino registre la CAGR más alta durante el período de pronóstico.
Según la aplicación, el mercado de la matriz extracelular se ha segmentado en reparación de tejidos blandos, reparación dural , cicatrización de heridas, reparación cardíaca, reparación pericárdica y reparación y reconstrucción vascular. Es probable que el segmento de reparación de tejidos blandos represente una mayor participación de mercado en 2021. Sin embargo, se espera que el segmento de reparación y reconstrucción vascular registre una CAGR más alta en el mercado durante el período de pronóstico.
Varias empresas que operan en el mercado de la matriz extracelular están adoptando estrategias de marketing, como lanzamientos de productos, fusiones y adquisiciones, colaboraciones, innovaciones de productos y expansiones de la cartera de productos para expandir su presencia en todo el mundo, mantener la marca y satisfacer la creciente demanda de los usuarios finales. .
Alcance del informe de mercado de matriz extracelular
Atributo del informe | Detalles |
---|---|
Tamaño del mercado en 2021 | US$ 31,49 millones |
Tamaño del mercado para 2028 | US$ 52,72 millones |
CAGR global (2021 - 2028) | 7,6% |
Información histórica | 2019-2020 |
Período de pronóstico | 2022-2028 |
Segmentos cubiertos | Por materia prima
|
Regiones y países cubiertos | América del norte
|
Líderes del mercado y perfiles clave de empresas |
|
- El PDF de muestra muestra la estructura del contenido y la naturaleza de la información con análisis cualitativo y cuantitativo.
Perfiles de empresa
- Anteris
- Aziyo Biologics, Inc.
- Grupo Coloplast
- Cook Biotecnología, Inc.
- DSM Biomédica
- baxter
- medtronic
- Merck KGaA
- Biológicos MTF
- Herrero y sobrino
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Global extracellular matrix market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa and South & Central America. In North America, the U.S. is the largest market for sleep apnea diagnostics. The market growth in the country is attributed to the rising prevalence of wounds and injuries. The growth of the market is mainly driven by the significant rise in cardiovascular disorders among the American population. And, Asia Pacific is the fastest-growing region growing at the CAGR of 8.2% during the forecast period.
The extracellular matrix market majorly consists of the players such as Anteris, Aziyo Biologics, Inc., Coloplast Group, Cook Biotech, Inc., DSM Biomedical, Baxter International, Inc., Medtronic, Merck KGaA, MTF Biologics, and Smith & Nephew, among others
The soft tissue repair segment dominated the global extracellular matrix market and accounted for the largest revenue share of 24.11% in 2021.
The Porcine segment dominated the global extracellular matrix market and held the largest revenue share of 43.76% in 2021.
Extracellular matrix is present in the outer side of the tissues and it helps tissues to bind the cells with collagen. It consists of structural proteins, glycoproteins, glycosaminoglycans and proteoglycans. Extracellular matrix enables recipient cells to regrow and thus it is used in various applications which include cardiac and vascular repair procedure.
Key factors that are driving the growth of this market are rising incidence of cardiovascular diseases and trauma along with increase in vascular reconstruction procedures.
The List of Companies - Extracellular Matrix Market
- Anteris
- Aziyo Biologics, Inc
- Coloplast Group
- Cook Biotech, Inc
- DSM Biomedical
- Baxter
- Medtronic
- Merck KGaA
- MTF Biologics
- Smith & Nephew
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.